Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02552719
Other study ID # IEQ2015
Secondary ID SNCTP000000442
Status Completed
Phase
First received
Last updated
Start date July 1, 2014
Est. completion date December 31, 2017

Study information

Verified date February 2021
Source University of Zurich
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Purpose of the study is the validation of the German version of the Injustice Experience Questionnaire. Pretest: Participants were informed about the aims of the study and fill in a consent form. They filled in a paper version of the German translation of the Injustice Experience Questionnaire. In a structured interview patients were asked if there were any items difficult to understand, unacceptable or offending them. Subsequently they had to answer questions about the content and meaning of the IEQ-items. Validation Study: Participants were informed about the aims of the study and filled in a consent form. By e-mail they received an access link to the online survey. The questionnaires of the survey could be filled in at home. The survey could be interrupted and terminated later. About 20 minutes were needed to answer the 80 questions of the survey. All data was saved anonymously during the survey.


Description:

Pretest: Participants were informed about the aims of the study and filled in a consent form. A paper version of the German translation of the Injustice Experience Questionnaire was completed in presence of the interviewer. The structure of the standardized interview followed the recommendations for pretesting transcultural translations of questionnaires. Patients were asked if there were any items difficult to understand, unacceptable or offending them. Subsequently they had to answer questions about the content and meaning of the IEQ-items. The interviewer asked all questions and entered the responses. All data were directly stored in a MySQL database at a Swiss commercial web-server (www.scientific-affairs.ch). Validation Study: Participants are informed about the aims of the study and fill in a consent sheet. By e-mail they receive an access link to the online survey which can be completed at home. The survey includes the following questionnaires: Injustice Experience Questionnaire (IEQ), Depression subscale of the Depression, Anxiety and Stress Scale (DASS), Tampa Scale for Kinesiophobia (TSK), McGill Pain Questionnaire (MPQ), Pain Catastrophizing Scale (PCS), Pain Disability Index (PDI) and part concerning causes of pain of the German Pain Questionnaire (DSF). About 20 minutes is needed to answer the 80 questions of the survey. After completing the survey participant can choose if they would like to be informed about the results of the filled in questionnaires. All data is saved anonymously during the survey and stored in a MySQL database at a Swiss commercial web-server (www.scientific-affairs.ch).


Recruitment information / eligibility

Status Completed
Enrollment 210
Est. completion date December 31, 2017
Est. primary completion date December 31, 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - pain (face, head or rest of the body) - good competence of German language - internet access - being able to fill in a web-based survey - adults Exclusion Criteria: - disuse / dependency on medication / drugs

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Germany Schmerzambulanz der Klinik für Anästhesiologie, Intensivmedizin und Schmerztherapie, Universitätsklinikum des Saarlandes Homburg Saarland
Germany DRK Schmerz-Zentrum Mainz Mainz Rheinland-Pfalz
Switzerland ANNR Rehaclinic Baden Aargau
Switzerland Zentrum für Schmerzmedizin, Schweizer Paraplegiker-Zentrum Nottwil Nottwil Luzern
Switzerland Kantonsspital St. Gallen, Schmerzzentrum St. Gallen Saint Gallen
Switzerland University of Zurich, Center of Dental Medicine Zurich

Sponsors (6)

Lead Sponsor Collaborator
University of Zurich Cantonal Hospital of St. Gallen, Deutsches Rotes Kreuz DRK-Blutspendedienst Baden-Wurttemberg-Hessen, Kantonsspital Baden, Swiss Paraplegic Centre Nottwil, University Hospital, Saarland

Countries where clinical trial is conducted

Germany,  Switzerland, 

References & Publications (9)

Dillmann U, Nilges P, Saile H, Gerbershagen HU. [Assessing disability in chronic pain patients.]. Schmerz. 1994 Jun;8(2):100-10. German. — View Citation

Kori S, Miller R, Todd D. Kinesiophobia: a new view of chronic pain behavior. Pain Management 1990:35-43

Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain. 1975 Sep;1(3):277-299. doi: 10.1016/0304-3959(75)90044-5. — View Citation

Meyer K, Sprott H, Mannion AF. Cross-cultural adaptation, reliability, and validity of the German version of the Pain Catastrophizing Scale. J Psychosom Res. 2008 May;64(5):469-78. doi: 10.1016/j.jpsychores.2007.12.004. — View Citation

Nigpur K, Russu AC. Fear of movement/(re)injury in chronic pain: Preliminary validation of a German version of the Tampa Scale for Kinesiophobia. European Journal of Pain 2009(13 (Supplement 1)):S239.

Pollard CA. Preliminary validity study of the pain disability index. Percept Mot Skills. 1984 Dec;59(3):974. — View Citation

Stein C, Mendl G. The German counterpart to McGill Pain Questionnaire. Pain. 1988 Feb;32(2):251-255. doi: 10.1016/0304-3959(88)90074-7. — View Citation

Sullivan MJ, Adams H, Horan S, Maher D, Boland D, Gross R. The role of perceived injustice in the experience of chronic pain and disability: scale development and validation. J Occup Rehabil. 2008 Sep;18(3):249-61. doi: 10.1007/s10926-008-9140-5. Epub 2008 Jun 7. — View Citation

Sullivan, Michael J. L., Bishop SR, Pivik J. The Pain Catastrophizing Scale: Development and validation. Psychological Assessment 1995;7(4):524-532

Outcome

Type Measure Description Time frame Safety issue
Primary Percentage of patients' confirmative responses related to the 12 IEQ-items in a questionnaire concerning 1) comprehensiveness, 2) acceptance, 3) offensiveness patients answered if the IEQ-items were
difficult to understand (yes/no)
unacceptable (yes/no)
offensive (yes/no)
10 months
Primary Percentage of non-confirmative responses of two raters about the patients' considerations about 1) the meaning of IEQ-items, 2) the chosen response option two raters judged if the patients' considerations about
the meaning of the IEQ-items was understood (yes/no)
the chosen response option was plausible (yes/no)
10 months
Primary Correlations between the IEQ score and the scores of the MPQ, DASS_D, TSK, PCS, PDI Correlations between the IEQ score and the scores of the MPQ, DASS_D, TSK, PCS, PDI are calculated and compared with the corresponding values English validation study. 7 months
Primary Number of factors as the result of a factor analysis of the IEQ-items Correspondence of the number of factors and the assigned items (as the result of a factor analysis) between the English and the German validation study 7 months
See also
  Status Clinical Trial Phase
Completed NCT02555462 - Real-Ear Measurement (REM) and Test Box System Integration Into Fitting Software N/A
Completed NCT03286270 - A mRUS Validation Study for Nail-treated Fractures of Long Bones and a TUS Exploratory Study for Nail and Plate-treated Fractures of Long Bones
Recruiting NCT01827527 - Magnetic Resonance & Optical Spectroscopy Validation
Completed NCT02888483 - PEAKS: Validation of Mobile Technologies
Active, not recruiting NCT03337321 - Developing and Validating Digital Affective Patient Experience/Outcome Measure
Completed NCT02455388 - d13C Added Sugar Intake Biomarker: Determining Validity in Children N/A
Completed NCT01836107 - Adaptation and Validation of a Score From English to Spanish for Evaluating Quality of Clinical Notes N/A